Twitter

Resumen del congreso #AES2019:
- llegada de las terapias genéticas
- tratando más que las crisis
- hay que cambiar el diseño de los ensayos
- los pacientes son parte del congreso
- test genetico gratuito (en América)

http://www.draccon.com/dracaena-report/aes-2019-es
#epilepsia

What I found the most interesting at #AES2019:
- the arrival of genetic therapies
- treating non-seizure aspects
- new clinical trial design needs
- bringing in patient advocates
- free genetic testing (for some)
http://www.draccon.com/dracaena-report/aes-2019
#epilepsy

https://www.facebook.com/roadsafetyadvertsuk/videos/145003519231771/ https://www.facebook.com/705348989/posts/10162794414688990/

In 2019 we raised over $2,300 for @CDKL5USA and #CDKL5 research with our artwork! Thank you for all your support and donations! We are excited for new projects in 2020 🌟

The Alzheimer's Research Daily is out! https://paper.li/ForTheResearch/1438836828?edition_id=87df2820-1db0-11ea-a278-0cc47a0d1605#!all Stories via @BrownAlumniMag @FrontNeurol @BianchisLab #alzheimers #dementia

Alzheimer’s drug candidates reverse broader aging

CMS121 and J147, two drug candidates that improve memory and slow neurodegeneration associated with Alzheimer’s disease, also slow aging in healthy, older mice.

https://zurl.co/aRug

#neuroscience #research #Alzheimers

Adrienne Griffen, of @PostpartumSupportVA: “We don’t talk about these illnesses, we let women fall off a cliff into the abyss of #Anxiety or #Depression and say, ‘Navigate the mental health system while you are taking care of a baby and feeling your absolute worst.’"

Carica altri...